An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment

T Motohara, K Masuda, M Morotti, Y Zheng… - Oncogene, 2019 - nature.com
Metastasis is a complex multistep process that involves critical interactions between cancer
cells and a variety of stromal components in the tumor microenvironment, which profoundly …

Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

[HTML][HTML] The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells

Z Hu, M Artibani, A Alsaadi, N Wietek, M Morotti, T Shi… - Cancer cell, 2020 - cell.com
The inter-differentiation between cell states promotes cancer cell survival under stress and
fosters non-genetic heterogeneity (NGH). NGH is, therefore, a surrogate of tumor resilience …

Ovarian cancer stem cells: still an elusive entity?

M Lupia, U Cavallaro - Molecular cancer, 2017 - Springer
The cancer stem cell (CSC) model proposes that tumor development and progression are
fueled and sustained by undifferentiated cancer cells, endowed with self-renewal and tumor …

Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer

Z Shonibare, M Monavarian, K O'Connell, D Altomare… - Cell reports, 2022 - cell.com
Growth factors in tumor environments are regulators of cell survival and metastasis. Here,
we reveal the dichotomy between TGF-β superfamily growth factors BMP and TGF-β/activin …

Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells

P Mukherjee, A Gupta, D Chattopadhyay, U Chatterji - Scientific reports, 2017 - nature.com
Tumor relapse in triple negative breast cancer patients has been implicated to
chemoresistant cancer stem cells (CSCs), which under favorable conditions culminate in …

[HTML][HTML] The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive …

E Cuyàs, J Gumuzio, S Verdura, J Brunet… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
SOX2 is a core pluripotency-associated transcription factor causally related to cancer
initiation, aggressiveness, and drug resistance by driving the self-renewal and seeding …

Serous tubal intraepithelial carcinomas associated with high‐grade serous ovarian carcinomas: a systematic review

F Chen, K Gaitskell, MJ Garcia… - … Journal of Obstetrics …, 2017 - Wiley Online Library
Background Serous tubal intraepithelial carcinomas (STIC s) have been documented in high‐
grade serous ovarian carcinomas (HGSOC s). However, the rate of association between …

Mechanisms of high-grade serous carcinogenesis in the fallopian tube and ovary: current hypotheses, etiologic factors, and molecular alterations

I Otsuka - International Journal of Molecular Sciences, 2021 - mdpi.com
Ovarian high-grade serous carcinomas (HGSCs) are a heterogeneous group of diseases.
They include fallopian-tube-epithelium (FTE)-derived and ovarian-surface-epithelium (OSE) …

Cancer and SOX proteins: new insight into their role in ovarian cancer progression/inhibition

M Ashrafizadeh, S Taeb, K Hushmandi, S Orouei… - Pharmacological …, 2020 - Elsevier
Transcription factors are potential targets in disease therapy, particularly in cancer. This is
due to the fact that transcription factors regulate a variety of cellular events, and their …